Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
81 hedge funds and large institutions have $17.5M invested in Ampio Pharmaceuticals Inc. in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 14 closing their positions.
243% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 7
143% more call options, than puts
Call options by funds: $784K | Put options by funds: $323K
56% more capital invested
Capital invested by funds: $11.2M → $17.5M (+$6.25M)
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
3% more funds holding
Funds holding: 79 → 81 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$542K |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$339K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$150K |
| 4 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
+$123K |
| 5 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMC
Private Capital Management (Colorado)
Denver,
Colorado
|
-$771K |
| 2 |
BlackRock
New York
|
-$65.7K |
| 3 |
TFS
TrustCore Financial Services
Brentwood,
Tennessee
|
-$49.1K |
| 4 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
-$25K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$21.6K |
AMPE Hedge Fund Activity: Q3 2020 in Review
81 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2020, worth a combined $17.5M — up 56% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new AMPE positions and 14 closed out — a net gain of 2 holders — while 24 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $542K. The largest seller was Private Capital Management (Colorado), exiting entirely with an estimated $771K sold.
- 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2020, up from 79 in Q2 2020.
- Funds reported $17.5M of Ampio Pharmaceuticals Inc. stock for Q3 2020, up 56% quarter-over-quarter.
- 16 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2020 and 14 closed out, a net change of +2 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2020 was Vanguard Group, an estimated $542K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2020 was Private Capital Management (Colorado), an estimated $771K sold.
Based on aggregated 13F filings for Q3 2020.